• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Gynaecol Obstet . COVID-19 vaccine hesitancy among pregnant and postpartum Kenyan women

tetano

Editor, Senior Moderator
Int J Gynaecol Obstet


. 2023 Apr 10.
doi: 10.1002/ijgo.14773. Online ahead of print.
COVID-19 vaccine hesitancy among pregnant and postpartum Kenyan women


Mary M Marwa[SUP] 1 [/SUP], John Kinuthia[SUP] 1 2 [/SUP], Anna Larsen[SUP] 2 3 4 [/SUP], Julia C Dettinger[SUP] 2 [/SUP], Laurén A Gomez[SUP] 2 [/SUP], Pascal Awino[SUP] 2 [/SUP], Felix Abuna[SUP] 1 [/SUP], Salphine Watoyi[SUP] 1 [/SUP], Ben Ochieng[SUP] 1 [/SUP], Nancy Ngumbau[SUP] 1 [/SUP], Grace John-Stewart[SUP] 2 3 5 [/SUP], Jillian Pintye[SUP] 2 6 [/SUP]



Affiliations

Abstract

Objective: The authors evaluated factors contributing to coronavirus disease 2019 (COVID-19) vaccine hesitancy among pregnant and postpartum women to inform vaccine scale-up strategies.
Methods: This observational study utilized data from pregnant and postpartum women attending four public maternal child health (MCH) clinics in Western Kenya. From October 2020 to July 2022, nurses assessed COVID-19 vaccine hesitancy, defined as reporting "unlikely" or "very unlikely" to the question, "If a vaccine for COVID-19 were available today, what is the likelihood that you would get vaccinated?"
Results: Among 1023 women (235 pregnant, 788 postpartum), 20% reported worsened MCH care during the pandemic and most (92%) perceived themselves or family members to be at risk for COVID-19, yet 54% of women reported COVID-19 vaccine hesitancy. Vaccine hesitancy was more frequent among women reporting worsened MCH care (P < 0.001) since the pandemic and those who did not trust the government as a source of COVID-19 information (P = 0.016). Over the 2-year period, willingness to receive the vaccine almost doubled (38% to 71%, P < 0.001).
Conclusions: Our findings suggest that sustaining access to quality MCH services may decrease COVID-19 vaccine hesitancy. Willingness to receive the vaccine doubled over the 2-year period in our cohort, suggesting increased trust for use and acceptance in the unique context of the pregnancy/postpartum period.

Keywords: COVID-19; Kenya; postpartum; pregnancy; vaccination; vaccine hesitancy.
 
Back
Top Bottom